UNICEF inks deal with Janssen Pharmaceutica to supply Covid-19 vaccine to AU

AFRICA – UNICEF has signed an agreement with Janssen Pharmaceutica to supply up to 220 million doses of the J&J single-dose vaccine for all 55 Member States of the African Union (AU) by the end of 2022. The agreement between UNICEF and Janssen Pharmaceutica NV will help implement the Advance Purchase Commitment (APC) signed between the African Vaccine Acquisition Trust (AVAT) and Janssen in March of this year. This agreement secured an option to order another 180 million doses, bringing the maximum access up to a total of 400 million doses by the end of…

Read More

US Food & Drug Administration grants Zydus Cadila tentative approval to market cancer drug

INDIA – Zydus Cadila has received tentative approval from the United States Food and Drug Administration (USFDA) to market Ibrutinib tablets used in the treatment of certain types of cancers. The company will market Ibrutinib tablets, in the strengths of 140 mg, 280 mg, 420 mg and 560 mg in the US though it will be manufactured at the group’s formulation manufacturing facility at Ahmedabad. Zydus Cadila now has 319 approvals and has so far filed over 400 abbreviated new drug applications (ANDAs) since the commencement of its filing process.…

Read More